{
  "source_file": "/content/drive/MyDrive/disorders/Schizophrenia_Spectrum_out/SubSection7_Substance_Medication_Induced_Psychotic_Disorder.txt",
  "hierarchy": {
    "file_name": "SubSection7_Substance_Medication_Induced_Psychotic_Disorder.txt",
    "location": "Schizophrenia_Spectrum_out > SubSection7_Substance_Medication_Induced_Psychotic_Disorder"
  },
  "embedding_model": "models/gemini-embedding-001",
  "embedding_dim": 3072,
  "chunks": [
    {
      "chunk_id": 0,
      "text_preview": "Substance/Medication-Induced Psychotic Disorder Diagnostic Criteria A. Presence of one or both of th"
    },
    {
      "chunk_id": 1,
      "text_preview": "should be listed separately (e.g., F12.259 severe cannabis use disorder with cannabis-induced psycho"
    },
    {
      "chunk_id": 2,
      "text_preview": "the highest rate (44%) for cannabis-induced psychotic disorder. 130 Diagnostic Markers With substanc"
    }
  ],
  "html_page": "Embedding/Schizophrenia_Spectrum_out/Substance_Medication_Induced_Psychotic_Disorder.html"
}